Cargando…
Gene therapy for a mouse model of glucose transporter-1 deficiency syndrome
OBJECTIVE: We generated an adeno-associated virus (AAV) vector in which the human SLC2A1 gene was expressed under the synapsin I promoter (AAV-hSLC2A1) and examined if AAV-hSLC2A1 administration can lead to functional improvement in GLUT1-deficient mice. METHODS: AAV-hSLC2A1 was injected into hetero...
Autores principales: | Nakamura, Sachie, Osaka, Hitoshi, Muramatsu, Shin-ichi, Takino, Naomi, Ito, Mika, Aoki, Shiho, Jimbo, Eriko F., Shimazaki, Kuniko, Onaka, Tatsushi, Ohtsuki, Sumio, Terasaki, Tetsuya, Yamagata, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238605/ https://www.ncbi.nlm.nih.gov/pubmed/28119822 http://dx.doi.org/10.1016/j.ymgmr.2016.12.008 |
Ejemplares similares
-
Gene Therapy in a Mouse Model of Niemann–Pick Disease Type C1
por: Kurokawa, Yoshie, et al.
Publicado: (2021) -
Drug screening for Pelizaeus-Merzbacher disease by quantifying the total levels and membrane localization of PLP1
por: Kouga, Takeshi, et al.
Publicado: (2019) -
Systemic Delivery of Tyrosine-Mutant AAV Vectors Results in Robust Transduction of Neurons in Adult Mice
por: Iida, Asako, et al.
Publicado: (2013) -
WDR45 variants cause ferrous iron loss due to impaired ferritinophagy associated with nuclear receptor coactivator 4 and WD repeat domain phosphoinositide interacting protein 4 reduction
por: Tsukida, Kiwako, et al.
Publicado: (2022) -
Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies
por: Ito, Mika, et al.
Publicado: (2021)